Type 2 Diabetes 2021

This supplement was sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. It was edited and peer reviewed by The Journal of Family Practice.
December 14, 2020|Clinician Reviews

The management of type 2 diabetes (T2D) has changed substantially over the last several decades. Standard practices have moved away from the glucocentric approach of T2D management into an era in which the interplay among T2D, obesity, atherosclerotic cardiovascular disease, heart failure, and chronic kidney disease is increas­ingly recognized.

This supplement to Clinician Reviews brings together key updates in the field of T2D to help care for patients who have not only T2D, but also other intercon­nected diseases. 

Supplementary Materials: 

Chapter 1: Evolution of Type 2 Diabetes Treatment

,

Plain Language Patient Summary: 

Infographic:

Chapter 2: A Practical Approach to Managing Kidney Disease in Type 2 Diabetes

Plain Language Patient Summary:

Infographic:

Chapter 3: Heart Failure in Patients with Type 2 Diabetes

Plain Language Patient Summary: 

Infographic:

Chapter 4: Overcoming Therapeutic Inertia: Practical Approaches

Plain Language Patient Summary:

Infographic:

Supplemental Materials are joint copyright © 2020 Frontline Medical Communications and Boehringer Ingelheim Pharmaceuticals, Inc.